GLP-1 juggernauts Eli Lilly and Novo Nordisk, whose combined $1.18 trillion market cap now exceeds Johnson & Johnson, AbbVie, and Merck combined, have staked their claim as stock market darlings. This momentum is particularly evident in Novo Nordisk’s remarkable trajectory, reaching a $604 billion market capitalization by March 2024 and securing its position as the…
This week in R&D: Eli Lilly opens large R&D center in Boston, Cisco cuts 5,900 jobs
The R&D World Index (RDWI) was up 2.91% with Cisco leading at 8.78%, in spite of its lay-off announcement. In the week ending August 16, the index closed at 3878.49 for the 25 companies in the RDWI. The Index was up 2.91% (or 109.53 basis points). Twenty-one RDWI members gained value last week from 0.95%…
An interactive 3D map of global innovation hubs
Silicon Valley is still where it’s at in terms of R&D. Yes, the region has cut roughly 45,000 tech jobs since 2022, but its dominance in research and development remains unchallenged, based on data from The 2023 EU Industrial R&D Investment Scoreboard. And despite the layoffs, many tech companies have reported significant revenue growth. NVIDIA…